Mala Vazirani, RPAC

Mala Vazirani practices at Schlanger, Gottlieb Partners Council Breast Imaging Center in Lake Success, New York.

Mala Vazirani's NPI, 1790762987, was assigned on December 28, 2005. Mala Vazirani holds New York license 006159.

Mala Vazirani's primary practice is Schlanger, Gottlieb Partners Council Breast Imaging Center, at 450 Lakeville Rd, Lake Success, NY 11042. The practice phone is (516) 734-8281.

Mala Vazirani's primary practice is Schlanger, Gottlieb Partners Council Breast Imaging Center in Lake Success, New York. Mala Vazirani is also affiliated with Long Island Jewish Medical Center. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Mala Vazirani to 1 more clinical lab and 1 medical group, each named with a free account. Mala Vazirani's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Mala Vazirani practices, 3 sites in all. Vendor and product names are available with a free account.

Medical is Mala Vazirani's primary specialty in the NPI Registry, under taxonomy code 363AM0700X. Mala Vazirani is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Mala Vazirani is licensed in New York.

Dmand AI lists contact dermatitis among the conditions Mala Vazirani treats.

CMS data shows 44 Medicare services from Mala Vazirani across 3 procedure codes in 2024, for 34 Medicare patients. Medicare paid $1,932 for them. Every service was in an office.

CMS counts 34 Medicare patients who saw Mala Vazirani in 2024. The largest group is 75 to 84, with 15 patients. 74% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mala Vazirani's median patient age at 66, with 59% women.

In 2024, Mala Vazirani wrote 194 Medicare Part D claims for 66 patients. 57% of them were for generic drugs. CMS names the drug for 103 of them, across 5 drugs with 11 or more claims each, at $56,860 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Mala Vazirani for performance year 2024, reported as part of a group. Mala Vazirani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Mala Vazirani as offering telehealth.